For indispensable reporting on the coronavirus crisis and more, subscribe to Mother Jones' newsletters.


The genetic engineering of farm animals raises all manner of vexing questions. And as gene tinkering applies to poultry, it even offers a reprise of the classic chicken-and-egg conundrum. To wit: Which came first, the chimera or the clone? 

The answer lies with two biotech firms, California-based Origen Therapeutics and Embrex of North Carolina, that are fine-tuning a process to mass-produce genetically uniform chickens—an effort boosted last July by a $4.7-million federal research grant from the National Institute of Science and Technology. “This is not cloning, per se,” says Joan Kureczka, spokeswoman for Origen, “but it is a way to produce, on a large scale, the ideal bird.” By injecting embryonic stem cells cultivated from a grade-A chicken into dozens, thousands, or even millions of newly laid eggs, Origen and Embrex hope to suppress the eggs’ natural genetic makeup and create “chimeras”—chicks that are near carbon copies, genetically speaking. (The companies may have also produced a few identical matches, or true clones.) Such uniformity is a tantalizing prospect for a poultry industry eager to streamline production: The engineered fowl would mature at the same rate, require the same amount of feed, and taste exactly the same. The technology is still a few years, and a number of regulatory hoops, away from market. But don’t be surprised if KFC one day becomes an acronym for Kentucky Fried Chimera.

Thank you!

We didn't know what to expect when we told you we needed to raise $400,000 before our fiscal year closed on June 30, and we're thrilled to report that our incredible community of readers contributed some $415,000 to help us keep charging as hard as we can during this crazy year.

You just sent an incredible message: that quality journalism doesn't have to answer to advertisers, billionaires, or hedge funds; that newsrooms can eke out an existence thanks primarily to the generosity of its readers. That's so powerful. Especially during what's been called a "media extinction event" when those looking to make a profit from the news pull back, the Mother Jones community steps in.

The months and years ahead won't be easy. Far from it. But there's no one we'd rather face the big challenges with than you, our committed and passionate readers, and our team of fearless reporters who show up every day.

Thank you!

We didn't know what to expect when we told you we needed to raise $400,000 before our fiscal year closed on June 30, and we're thrilled to report that our incredible community of readers contributed some $415,000 to help us keep charging as hard as we can during this crazy year.

You just sent an incredible message: that quality journalism doesn't have to answer to advertisers, billionaires, or hedge funds; that newsrooms can eke out an existence thanks primarily to the generosity of its readers. That's so powerful. Especially during what's been called a "media extinction event" when those looking to make a profit from the news pull back, the Mother Jones community steps in.

The months and years ahead won't be easy. Far from it. But there's no one we'd rather face the big challenges with than you, our committed and passionate readers, and our team of fearless reporters who show up every day.

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.